Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-232857
Filing Date
2026-05-20
Accepted
2026-05-20 17:22:39
Documents
84
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sclx-20260331.htm   iXBRL 10-Q 4198897
2 EX-4.21 sclx-ex4_21.htm EX-4.21 104766
3 EX-10.2 sclx-ex10_2.htm EX-10.2 90581
4 EX-10.3 sclx-ex10_3.htm EX-10.3 623239
5 EX-31.1 sclx-ex31_1.htm EX-31.1 14510
6 EX-31.2 sclx-ex31_2.htm EX-31.2 14003
7 EX-32.1 sclx-ex32_1.htm EX-32.1 13951
  Complete submission text file 0001193125-26-232857.txt   21029490

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sclx-20260331.xsd EX-101.SCH 3204496
88 EXTRACTED XBRL INSTANCE DOCUMENT sclx-20260331_htm.xml XML 3547303
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39852 | Film No.: 261005154
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)